OmacorĀ® (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia Heinz Rupp Review 27 July 2009 Pages: 675 - 690
Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases Kai M. BeehJutta Beier Review 16 July 2009 Pages: 691 - 699
Aliskiren, the first approved renin inhibitor: Clinical application and safety in the treatment of hypertension Graziano RiccioniNicola VitulanoFulvio Bellocci Review 27 July 2009 Pages: 700 - 710
Dyslipidemia therapy update: the importance of full lipid profile assessment I. B. A. MenownG. MurtaghG. Tomkin Review 27 July 2009 Pages: 711 - 718
Therapeutic effect of 1,5-pentanediol for herpes simplex labialis: a randomized, double-blind, placebo-controlled clinical trial Regina BuschHans-Joachim GraubaumJan Faergemann Original Research 27 July 2009 Pages: 719 - 727
Comparing hydrocortisone and methylprednisolone in patients with septic shock Teng-Jen YuYu-Chih LiuHuang-Pin Wu Original Research 23 July 2009 Pages: 728 - 735
Erratum to: Saxagliptin: a New DPP-4 inhibitor for the treatment of type 2 diabetes mellitus Abd A. TahraniMilan K. PiyaAnthony H. Barnett Erratum 01 August 2009 Pages: 736 - 736
Erratum to: Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis Kit N. SimpsonMary Jane WelchZiad Nahas Erratum 01 August 2009 Pages: 737 - 737